Abstract:Random screening suggested that the EtOH extract of Artemisia myriantha (Asteraceae) and its EtOAc fraction had cytotoxicity against HepG2 cells with inhibitory ratios of 30.6% and 53.5% at 50.0 μg/mL. Bioassay-guided isolation of the most active fractions (Fr. C and Fr. D) afforded 19 new sesquiterpenolides, artemyrianolides A–S (1–19), involving 13 germacranolides (1–13), four guaianolides (14–17), and two eudesmanolides (18 and 19), together with 16 known sesquiterpenoids (20–35). The new compounds were characterized by physical data analyses (HRESIMS, IR, 1D and 2D NMR, ECD), and the absolute configurations of compounds 1, 2, and 11 were determined by X-ray crystallography. Structurally, compounds 2 and 11–13 maintain an uncommon cis-fused 10/5 bicyclic system and compound 12 possesses an unusual (7S) configuration. Twenty of the compounds exhibited cytotoxicity against HepG2, Huh7, and SMMC-7721 cell lines. Compound 9 showed cytotoxic activity on both HepG2 and Huh7 cells with IC50 values of 8.6 and 8.8 μM, and compounds 8 and 33 showed cytotoxicity to the three human hepatoma cell lines with IC50 values of 4.9 and 7.4 μM (HepG2), 4.3 and 7.8 μM (Huh7), and 3.1 and 9.8 μM (SMMC-7721), respectively.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jnatprod.0c00396?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jnatprod.0c00396</a>.Structures of known compounds 20–35; preassayed result of cytotoxicity for the isolates against HepG2 cells; experimental and calculated ECD spectra of compounds 10 and 12–19; HRESIMS, [α]D, IR, UV, 1D and 2D NMR spectra of compounds 1–19 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jnatprod.0c00396/suppl_file/np0c00396_si_001.pdf">PDF</a>)X-ray crystallographic data of compound 1 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jnatprod.0c00396/suppl_file/np0c00396_si_002.cif">CIF</a>)X-ray crystallographic data of compound 2 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jnatprod.0c00396/suppl_file/np0c00396_si_003.cif">CIF</a>)X-ray crystallographic data of compound 11 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jnatprod.0c00396/suppl_file/np0c00396_si_004.cif">CIF</a>)This article has not yet been cited by other publications.

Extracellular Signal-Regulated Kinases (erk) Inhibitors from Aristolochia Yunnanensis

Two New Aristolochic Acid Analogues from the Roots of Aristolochia contorta with Significant Cytotoxic Activity

New Aristolochic Acid, Aristololactam and Renal Cytotoxic Constituents from the Stem and Leaves of Aristolochia Contorta.

[A New Aristolochic Acid Derivative from Asarum Himalaicum].

Phenanthrene Derivatives from Roots and Rhizomes of Asarum Heterotropoides Var. Mandshuricum.

Cytotoxicity of Phenanthrenes Extracted from Aristolochia Contorta in Human Proximal Tubular Epithelial Cell Line

Isolation, structural elucidation and anti-inflammatory activity of astragalin, (-)hinokinin, aristolactam I and aristolochic acids (I & II) from Aristolochia indica

Triterpenoids, steroids and other constituents from Euphorbia kansui and their anti-inflammatory and anti-tumor properties

Studies on Morphology and Aristolochic Acid Analogue Constituents of Asarum Campaniflorum and a Comparison with Two Official Species of Asari Radix Et Rhizoma

In vitro anti-inflammatory, anticancer effects and phytochemical characterisation of organic extracts from Aristolochia olivieri Colleg. ex Boiss

5–Methoxyaristololactam I, the First Natural 5–substituted Aristololactam from Asarum Ichangense

Cytotoxic Monoterpenoid Indole Alkaloids from Alstonia Yunnanensis Diels

Artemyrianolides A–S, Cytotoxic Sesquiterpenoids from Artemisia myriantha

Heteryunine A, an amidated tryptophan-catechin-spiroketal hybrid with antifibrotic activity from Heterosmilax yunnanensis

Aristolic Acid Derivatives from the Bark of Antidesma ghaesembilla

[Isolation and Identification of Three New Alkaloids from the Roots of Alstonia Yunnanensis Diels Indiana, USA].

5-epi-ent-Kaurane diterpenoids from the aerial parts of Isodon eriocalyx and their anti-atherosclerotic potential

In Vitro Nephrotoxicity and Quantitative UPLC-MS Analysis of Three Aristololactams in Houttuynia Cordata.

New eudesmanolides from Artemisia verlotorum and their potential targets of hepatocellular carcinoma by network pharmacology

Design, synthesis, and antitumor activity of novel oleanolic acid analogues targeting EGFR

Isolation and purification of six aristolochic acids with similar structures from Aristolochia manshuriensis Kom stems by pH-zone-refining counter-current chromatography